Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Dried Blood Spot Methodology in Combination With Liquid Chromatography/Tandem Mass Spectrometry Facilitates the Monitoring of Teriflunomide.
Brain parenchymal damage in neuromyelitis optica spectrum disorder - A multimodal MRI study.
Endogenous retroviruses and multiple sclerosis--new pieces to the puzzle.
Anti-phospholipid antibodies are associated with response to interferon-beta1a treatment in MS: results from a 3-year longitudinal study.
Norovirus-related chronic diarrhea in a patient treated with alemtuzumab for chronic lymphocytic leukemia.
Daclizumab reverses intrathecal immune cell abnormalities in multiple sclerosis.
Placebo? no thanks, it might be bad for me!
High risk of MS in Iranian immigrants in Gothenburg, Sweden.
Using experimental autoimmune encephalomyelitis as a model to study the effect of prenatal stress on fetal programming.
Low vitamin B12 levels and gastric parietal cell antibodies in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders.
Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
Ocrelizumab in multiple sclerosis: risks and benefits.
An Intricate Mechanism of Action of Avonex in Relapsing Remitting Multiple Sclerosis Patients: Variation of Serum Titre of Interleukin-17A, Interleukin-10 and Transforming Growth Factor-β.
Effect of treatment with interferon beta-1a on changes in voxel-wise magnetization transfer ratio in normal appearing brain tissue and lesions of patients with relapsing-remitting multiple sclerosis: a 24-week, controlled pilot study.
Magnetic Resonance Spectroscopy Markers of Disease Progression in Multiple Sclerosis.
The mammalian Na+/H+ exchanger gene family--initial structure/function studies.
Noninvasive molecular imaging of neuroinflammation.
Protective Associations of HDL with Blood Brain Barrier Injury in Multiple Sclerosis Patients.
The VP1 subunit of JC polyomavirus recapitulates early events in viral trafficking and is a novel tool to study polyomavirus entry.
Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, th17- and activated B-cells and correlates with progression.
Randomized, open-label study to evaluate patient-reported outcomes with fingolimod after changing from prior disease-modifying therapy for relapsing multiple sclerosis: EPOC study rationale and design.
Birth outcomes of pregnancies fathered by men with multiple sclerosis.
The Submaximal Clinical Exercise Tolerance Test (SXTT) to Establish Safe Exercise Prescription Parameters for Patients with Chronic Disease and Disability.
How Natalizumab Binds and Antagonizes α4 Integrins.
Pharmacokinetics and pharmacodynamics of MD1003 (high-dose biotin) in the treatment of progressive multiple sclerosis.

Pages